AICHER THOMAS DANIEL,BOYD STEVEN ARMEN,CHICARELLI MARK JOSEPH,CONDROSKI KEVIN RONALD,FELL JAY BRADFORD,FISCHER JOHN P,GUNAWARDANA INDRANI W,HINKLIN RONALD JAY,SINGH AJAY,TURNER TIMOTHY M,WALLACE ELI M
申请号：
ZA201102350
公开号：
ZA201102350B
申请日:
2011.03.29
申请国别(地区):
ZA
年份:
2012
代理人:
摘要：
Provided are compounds of Formula I wherein R 2 , R 3 , R 13 , L and D 2 are as defined in the specification, which are useful in the treatment and/or prevention of diseases or disorders mediated by deficient levels of glucokinase activity or which can be treated by activating glucokinase including, but not limited to, diabetes mellitus, impaired glucose tolerance, IFG (impaired fasting glucose) and IFG (impaired fasting glycemia), as well as other diseases and disorders such as those discussed herein.
